1	Tyloxapol	Tyloxapol	_	_	_	_	_	_	_
2	inhibits	inhibit	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	cytokine	cytokine	_	_	_	_	_	_	_
7	release	release	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	scavenges	scavenge	_	_	_	_	_	_	_
10	HOCI	HOCI	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	reduces	reduce	_	_	_	_	_	_	_
14	viscosity	viscosity	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	cystic	cystic	_	_	_	_	_	_	_
17	fibrosis	fibrosis	_	_	_	_	_	_	_
18	sputum	sputum	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Cystic	cystic	_	_	_	_	_	_	_
2	fibrosis	fibrosis	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	CF	CF	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	patients	patient	_	_	_	_	_	_	_
7	develop	develop	_	_	_	_	_	_	_
8	progressive	progressive	_	_	_	_	_	_	_
9	cytokine-mediated	cytokine-mediated	_	_	_	_	_	_	_
10	inflammatory	inflammatory	_	_	_	_	_	_	_
11	lung	lung	_	_	_	_	_	_	_
12	disease	disease	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	abundant	abundant	_	_	_	_	_	_	_
16	production	production	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	thick	thick	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	tenacious	tenacious	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	protease-	protease-	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	oxidant-rich	oxidant-rich	_	_	_	_	_	_	_
25	purulent	purulent	_	_	_	_	_	_	_
26	airway	airway	_	_	_	_	_	_	_
27	secretions	secretion	_	_	_	_	_	_	_
28	that	that	_	_	_	_	_	_	_
29	are	be	_	_	_	_	_	_	_
30	difficult	difficult	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	clear	clear	_	_	_	_	_	_	_
33	even	even	_	_	_	_	_	_	_
34	with	with	_	_	_	_	_	_	_
35	physiotherapy	physiotherapy	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	search	search	_	_	_	_	_	_	_
4	for	for	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	potential	potential	_	_	_	_	_	_	_
7	treatment	treatment	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	we	we	_	_	_	_	_	_	_
10	have	have	_	_	_	_	_	_	_
11	tested	test	_	_	_	_	_	_	_
12	tyloxapol	tyloxapol	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	an	an	_	_	_	_	_	_	_
15	alkylaryl	alkylaryl	_	_	_	_	_	_	_
16	polyether	polyether	_	_	_	_	_	_	_
17	alcohol	alcohol	_	_	_	_	_	_	_
18	polymer	polymer	_	_	_	_	_	_	_
19	detergent	detergent	_	_	_	_	_	_	_
20	previously	previously	_	_	_	_	_	_	_
21	used	use	_	_	_	_	_	_	_
22	as	as	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	mucolytic	mucolytic	_	_	_	_	_	_	_
25	agent	agent	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	adult	adult	_	_	_	_	_	_	_
28	chronic	chronic	_	_	_	_	_	_	_
29	bronchitis	bronchitis	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Tyloxapol	Tyloxapol	_	_	_	_	_	_	_
2	inhibits	inhibit	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	factor-kappa	factor-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	NK-kappa	NK-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	reduces	reduce	_	_	_	_	_	_	_
17	resting	rest	_	_	_	_	_	_	_
18	secretion	secretion	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	cytokine	cytokine	_	_	_	_	_	_	_
22	interleukin-8	interleukin-8	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	IL-8	il-8	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	cultured	culture	_	_	_	_	_	_	_
28	human	human	_	_	_	_	_	_	_
29	monocytes	monocyte	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	inhibits	inhibit	_	_	_	_	_	_	_
33	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	LPS)-stimulated	lps)-stimulated	_	_	_	_	_	_	_
36	release	release	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	tumor	tumor	_	_	_	_	_	_	_
39	necrosis	necrosis	_	_	_	_	_	_	_
40	factor-alpha	factor-alpha	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	IL-1	il-1	_	_	_	_	_	_	_
46	beta	beta	_	_	_	_	_	_	_
47	,	,	_	_	_	_	_	_	_
48	IL-6	IL-6	_	_	_	_	_	_	_
49	,	,	_	_	_	_	_	_	_
50	IL-8	IL-8	_	_	_	_	_	_	_
51	,	,	_	_	_	_	_	_	_
52	granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
53	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
54	factor	factor	_	_	_	_	_	_	_
55	(	(	_	_	_	_	_	_	_
56	GM-CSF	GM-CSF	_	_	_	_	_	_	_
57	)	)	_	_	_	_	_	_	_
58	,	,	_	_	_	_	_	_	_
59	and	and	_	_	_	_	_	_	_
60	the	the	_	_	_	_	_	_	_
61	eiconsanoids	eiconsanoid	_	_	_	_	_	_	_
62	thromboxane	thromboxane	_	_	_	_	_	_	_
63	A2	a2	_	_	_	_	_	_	_
64	and	and	_	_	_	_	_	_	_
65	leukotriene	leukotriene	_	_	_	_	_	_	_
66	B4	b4	_	_	_	_	_	_	_
67	(	(	_	_	_	_	_	_	_
68	LTB4	ltb4	_	_	_	_	_	_	_
69	)	)	_	_	_	_	_	_	_
70	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	previously	previously	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	tyloxapol	tyloxapol	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	potent	potent	_	_	_	_	_	_	_
10	antioxidant	antioxidant	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	hydroxyl	hydroxyl	_	_	_	_	_	_	_
13	radicals	radical	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	OH).	OH).	_	_	_	_	_	_	_
16	Tyloxapol	Tyloxapol	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	0.05	0.05	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	0.1	0.1	_	_	_	_	_	_	_
21	%	%	_	_	_	_	_	_	_
22	wt/vol	wt/vol	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	effectively	effectively	_	_	_	_	_	_	_
25	scavenges	scavenge	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	oxidant	oxidant	_	_	_	_	_	_	_
28	hypochlorous	hypochlorous	_	_	_	_	_	_	_
29	acid	acid	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	HOCl	HOCl	_	_	_	_	_	_	_
32	;	;	_	_	_	_	_	_	_
33	1	1	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	7.5	7.5	_	_	_	_	_	_	_
36	mM	mm	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	in	in	_	_	_	_	_	_	_
39	vitro	vitro	_	_	_	_	_	_	_
40	,	,	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	protects	protect	_	_	_	_	_	_	_
43	from	from	_	_	_	_	_	_	_
44	HOCl-mediated	hocl-mediated	_	_	_	_	_	_	_
45	lung	lung	_	_	_	_	_	_	_
46	injury	injury	_	_	_	_	_	_	_
47	in	in	_	_	_	_	_	_	_
48	rats	rat	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	Tyloxapol	Tyloxapol	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	reduces	reduce	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	viscosity	viscosity	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	CF	CF	_	_	_	_	_	_	_
8	sputum	sputum	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	463	463	_	_	_	_	_	_	_
12	+/-	+/-	_	_	_	_	_	_	_
13	133	133	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	128	128	_	_	_	_	_	_	_
16	+/-	+/-	_	_	_	_	_	_	_
17	52	52	_	_	_	_	_	_	_
18	centipoise	centipoise	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	conclude	conclude	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	tyloxapol	tyloxapol	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	potentially	potentially	_	_	_	_	_	_	_
7	useful	useful	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	new	new	_	_	_	_	_	_	_
11	antiinflammatory	antiinflammatory	_	_	_	_	_	_	_
12	therapy	therapy	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	CF	CF	_	_	_	_	_	_	_
15	lung	lung	_	_	_	_	_	_	_
16	disease	disease	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	could	could	_	_	_	_	_	_	_
20	possibly	possibly	_	_	_	_	_	_	_
21	promote	promote	_	_	_	_	_	_	_
22	clearance	clearance	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	secretions	secretion	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	CF	CF	_	_	_	_	_	_	_
28	airway	airway	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

